113 related articles for article (PubMed ID: 36626282)
1. Training workload in the investigational drug service of a university hospital center.
Martel-Côté N; Choquette R; Côté-Sergerie C; Lebel D; Bussières JF; Tanguay C
Am J Health Syst Pharm; 2023 Apr; 80(8):495-502. PubMed ID: 36626282
[TBL] [Abstract][Full Text] [Related]
2. Development of complexity categories for an investigational drug services complexity scoring tool to assess pharmacy effort in clinical trial initiation and maintenance.
Song K; Yu M; McLuckie R; O'Brien K; Harrison M; Nguyen V; Kraft M; Abdelghany O; Phillips MS; Roberts J; Johnston S; Young CA; Redic KA
Am J Health Syst Pharm; 2023 Oct; 80(21):1557-1563. PubMed ID: 37335865
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Economic Value of Pharmacy Resident Participation in an Investigational Drug Service.
Brown JN; Gordon SE; Tillman F; Jacob S; Britnell SR
J Pharm Pract; 2021 Feb; 34(1):23-27. PubMed ID: 31232150
[TBL] [Abstract][Full Text] [Related]
4. The financial impact of investigational drug services.
Rogers SD; Lampasona V; Buchanan EC
Top Hosp Pharm Manage; 1994 Apr; 14(1):60-6. PubMed ID: 10133561
[TBL] [Abstract][Full Text] [Related]
5. Pharmacy-coordinated investigational drug services.
Stolar MH; Gabriel T; Grant KL; Koeller J; Letendre DE
Am J Hosp Pharm; 1982 Mar; 39(3):232-6. PubMed ID: 7072723
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the effects of a global pandemic on the operation of an investigational drug service.
Coulter C; Thorne A; Amerine L
Am J Health Syst Pharm; 2023 Apr; 80(9):e126-e130. PubMed ID: 36745616
[TBL] [Abstract][Full Text] [Related]
7. Improving investigational drug service operations through development of an innovative computer system.
Sweet BV; Tamer HR; Siden R; McCreadie SR; McGregory ME; Benner T; Tankanow RM
Am J Health Syst Pharm; 2008 May; 65(10):969-73. PubMed ID: 18463347
[TBL] [Abstract][Full Text] [Related]
8. Development and funding of a pharmacy-based investigational drug service.
Ryan ML; Colvin CL; Tankanow RM
Am J Hosp Pharm; 1987 May; 44(5):1069-74. PubMed ID: 3605116
[TBL] [Abstract][Full Text] [Related]
9. A survey of pharmacy-coordinated investigational drug services.
Cipywnyk DM; McBride J
Can J Hosp Pharm; 1991 Aug; 44(4):183-8, 200. PubMed ID: 10112895
[TBL] [Abstract][Full Text] [Related]
10. Investigational drug labeling variability.
Duhamel A; Thibault M; Lebel D; Bussières JF; Tanguay C
Clin Trials; 2019 Apr; 16(2):204-213. PubMed ID: 30714394
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
12. Operation of a radiopharmacy for a clinical trial.
Norenberg JP; Petry NA; Schwarz S
Semin Nucl Med; 2010 Sep; 40(5):347-56. PubMed ID: 20674594
[TBL] [Abstract][Full Text] [Related]
13. Consent documents for oncology trials: does anybody read these things?
Sharp SM
Am J Clin Oncol; 2004 Dec; 27(6):570-5. PubMed ID: 15577434
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Length and Readability of Informed Consent Documents for COVID-19 Vaccine Trials.
Emanuel EJ; Boyle CW
JAMA Netw Open; 2021 Apr; 4(4):e2110843. PubMed ID: 33909052
[TBL] [Abstract][Full Text] [Related]
15. Clinical research: business opportunities for pharmacy-based investigational drug services.
Marnocha RM
Am J Health Syst Pharm; 1999 Feb; 56(3):249-52. PubMed ID: 10030512
[TBL] [Abstract][Full Text] [Related]
16. Pharmacy-based investigational drug services: a national survey.
Rockwell K
Top Hosp Pharm Manage; 1993 Apr; 13(1):1-15. PubMed ID: 10128788
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Marketing an investigational drug service.
Johnson VB; Crane V; Hayman JN
Top Hosp Pharm Manage; 1993 Apr; 13(1):16-28. PubMed ID: 10128789
[TBL] [Abstract][Full Text] [Related]
19. A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use.
Formea CM; Weiss WT; McCluskey SV
Am J Health Syst Pharm; 2008 Jul; 65(13):1266-9. PubMed ID: 18574018
[TBL] [Abstract][Full Text] [Related]
20. SIMulation of Medication Error induced by Clinical Trial drug labeling: the SIMME-CT study.
Dollinger C; Schwiertz V; Sarfati L; Gourc-Berthod C; Guédat MG; Alloux C; Vantard N; Gauthier N; He S; Kiouris E; Caffin AG; Bernard D; Ranchon F; Rioufol C
Int J Qual Health Care; 2016 Jun; 28(3):311-5. PubMed ID: 26976831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
